Therapeutic Approach

Archive: October, 2015

Ritter Pharmaceuticals Appoints William J. Sandborn, M.D. to Medical Advisory Board

LOS ANGELES (October 21, 2015) – Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR), a pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases, today announced the appointment of William J. Sandborn, M.D. to its Medical Advisory Board. Michael D. Step, Chief Executive Officer of Ritter Pharmaceuticals, commented, ”We are excited […]

Leave Your Comments »

Ritter Pharmaceuticals Appoints AnnKatrin Petersen-Jappelli, M.D., M.SC. as Chief Medical Officer

LOS ANGELES (October 6, 2015) – Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (Ritter Pharmaceuticals or the Company), a pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases, today announced the appointment of AnnKatrin Petersen-Jappelli, M.D., M.Sc. as its Chief Medical Officer. Michael D. Step, Chief Executive Officer of Ritter […]

Leave Your Comments »

Ritter Pharmaceuticals to Present at the 2015 Aegis Growth Conference

LOS ANGELES (October 6, 2015) – Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (Ritter Pharmaceuticals or the Company), a pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases, today announced that Michael Step, Chief Executive Officer, will present a corporate overview at the 2015 Aegis Growth Conference on Thursday, October […]

Leave Your Comments »

Featuring Recent Posts WordPress Widget development by YD